March 26, 2025 09:24 PM EDT
Startups
Deals

Au­ri­on CEO is out as Al­con takes ma­jor­i­ty stake in cell ther­a­py start­up

Andrew Dunn

Senior Biopharma Correspondent

Eye gi­ant Al­con said Wednes­day it ac­quired a ma­jor­i­ty stake in cell ther­a­py start­up Au­ri­on and re­placed CEO Greg Kun­st, the lat­est twist in a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Fed­er­al judge nix­es FDA's lab-de­vel­oped test rule, says it ex­ceed­ed agen­cy's au­thor­i­ty

What’s next af­ter Marks? At FDA, ques­tions over more top ex­its and fu­ture vi­sion for drug agency

Marks’ ex­it at FDA rat­tles an al­ready tee­ter­ing biotech in­dus­try

Lil­ly's heart dis­ease drug could be dosed as lit­tle as once a year, study shows

Mer­ck’s PAH drug cuts risk of se­ri­ous events by 76% in tri­al stopped for ef­fi­ca­cy

sponsored

End­points we­bi­nar: In­side the “One Lon­za” strat­e­gy: Re-en­gi­neer­ing the fu­ture of CD­MO

A service from the Financial Times